Takeda Pharmaceuticals America Inc | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Takeda Pharmaceuticals America Inc

Sort by

Viewing results 1‒25 of 3373

Brazil
Brazil rolls out dengue vaccines as cases rise sharply
...This month Brazil started distributing a vaccine produced by Japanese pharmaceutical group Takeda....
February 25, 2024
Special ReportThe Americas’ Fastest Growing Companies
Its blockbuster cystic fibrosis treatment costs $300,000 a year. Now Vertex wants to solve the opioid crisis
...So effective is Vertex Pharmaceuticals’ blockbuster cystic fibrosis (CF) drug, Trikafta, that studies project it could extend the lives of some young patients by up to 45 years....
April 26, 2024
FT Live
Innovative Lawyers Awards North America
Celebrating innovations from both law firms and in-house teams in the region
Monday, 9 DecemberGotham Hall, Broadway, New York, NY, USA
News in-depthDementia
Alzheimer’s drug Leqembi falls short of blockbuster status in faltering US rollout
...It was unbelievable,” said Alisha Alaimo, Biogen’s North America head....
April 22, 2024
Insider trading
Ex-Pfizer employee charged with insider trading over Covid treatment
...Joseph Dupont, then a vice-president at Alexion Pharmaceuticals, now owned by AstraZeneca, shared knowledge of an upcoming acquisition of Portola Pharmaceuticals with Shawn Cronin, a childhood friend and...
June 29, 2023
US politics & policy
US targets 10 drugs for pricing negotiations in crackdown on costs
...The US government named 10 of the best-selling drugs as the first to face tough price regulations in a bid to slash healthcare costs, marking the biggest shake-up for the pharmaceutical industry in decades...
August 29, 2023
On Wall StreetJames Fontanella-Khan
Banker glee does not tell the whole story on Lina Khan setbacks
...The animus towards her in finance and corporate America might indicate she is having an impact despite the setbacks. The Amazon case will be a big test....
September 9, 2023
FT Live
Infrastructure Investment in Latin America and the Caribbean
Identifying opportunities for investors and asset managers
Wednesday, 12 June237 Park Avenue, New York, NY, USA
Due Diligence
The coming wave of private capital consolidation Premium content
...Goldman, Bank of America, JPMorgan Chase, Morgan Stanley, Citi and UBS are on the deal....
January 16, 2024
Pharmaceuticals sector
Use of horseshoe crabs’ blue blood puts pharma groups under scrutiny
...In May, the Pharmaceutical Supply Chain Initiative, a lobby set up by large pharmaceutical companies, said its members should stop sourcing blood from the two Asian horseshoe crab species most at risk....
August 22, 2023
Dementia
US regulators approve first drug to slow progression of Alzheimer’s
...It comes after decades during which many big pharmaceutical companies lost hope and cut investment in Alzheimer’s research....
July 6, 2023
Mergers & Acquisitions
M&A crackdown a ‘disaster’ for pharma sector, Pfizer executive warns
...Dan Mead, head of the investment-grade syndicate at Bank of America — a lead bookrunner on the Pfizer bond sale — said it was “not uncommon to see that for financings”....
May 17, 2023
Johnson & Johnson Co Inc
J&J consumer arm’s shares jump in biggest US IPO since 2021
...Goldman Sachs, JPMorgan Chase and Bank of America were lead underwriters on the listing....
May 4, 2023
Behind the Money podcast35 min listen
Best Of: Inside Johnson & Johnson’s bankruptcy two-step
...The FT’s US pharmaceutical correspondent Jamie Smyth helps us explore whether J&J’s use of this manoeuvre is setting a precedent for corporations to evade accountability in America....
May 31, 2023
AbbVie Inc
Blockbuster AbbVie drug Humira to face competition in US for first time
Amgen to launch ‘biosimilar’ version of medicine that has generated $200bn in sales since launch
January 31, 2023
Pfizer Inc
Pfizer pins hopes on record pipeline to recover from post-Covid hangover
...The US drugmaker has spent almost $30bn on acquisitions over the past two years, snapping up Arena Pharmaceuticals, Biohaven Pharmaceuticals, Global Blood Therapeutics, ReViral and Trillium Therapeutics....
February 21, 2023
News in-depthBankruptcy
Talc ruling a blow to J&J and the ‘Texas two-step’ bankruptcy jig
...But they warn that the ruling casts a shadow over the company as it seeks to remodel itself as an innovator in the pharmaceutical and medical devices sectors....
February 6, 2023
FT Live
Future of Asset Management North America
New models for the next age of fund management
Wednesday, 25 SeptemberNew York, NY, USA
Pharmaceuticals sector
GSK and Sanofi shares surge after Zantac ruling victory
...The ruling was a significant win for the pharmaceutical companies GSK, Pfizer, Sanofi and Boehringer Ingelheim....
December 6, 2022
Coronavirus treatment
Merck antiviral trial shows promising impact on Covid recovery time
...“We are encouraged by these findings from Panoramic,” said Merck, which is known as MSD outside North America....
December 22, 2022
Pharmaceuticals sector
Merck in talks over $40bn deal for cancer biotech SeaGen
...SeaGen also recently signed a partnership with French drugmaker Sanofi and has agreements with Takeda and Bristol Myers Squibb among others. SeaGen declined to comment....
July 7, 2022
Health sector
Alzheimer’s drug trial brings pivotal test of maligned brain plaque theory
...The phase 3 trial is being led by Eisai, a Tokyo-based pharmaceutical company that has partnered US biotech Biogen to develop lecanemab....
September 23, 2022
Illumina Inc
Illumina to challenge Brussels over any block on Grail merger
US biotech to object to impending EU ruling on $8bn deal for cancer screening group
September 5, 2022
InterviewLeadership
Philip Morris’s CEO on quitting smoking and detoxifying the brand
...But the first few that did join the company learnt that the drive to develop reduced-risk tobacco products that help people quit smoking could save more lives than many pharmaceutical products....
March 5, 2023
Covid-19 vaccines
US approves Omicron vaccines from Moderna and BioNTech/Pfizer
FDA clears jabs despite lack of human trials in effort to curb winter wave of Covid infections
August 31, 2022
Pharmaceuticals sector
Biogen drug slows progress of motor neurone disease in landmark trial
...The US company’s drug tofersen targets a defective gene called SOD1, which causes about 2 per cent of cases of MND, also known as amyotrophic lateral sclerosis or ALS in North America....
September 21, 2022
Covid-19 vaccines
Pfizer and BioNTech ask US regulator to authorise variant-specific jab
Vaccine targeting BA.4/BA.5 could become first shot to win green light without human trials
August 22, 2022
Behind the Money podcast18 min listen
Who will pay for the next Covid vaccines?
...In this week’s episode, we hear from White House Covid coordinator Ashish Jha, professor of molecular medicine and cardiologist Eric Topol and the FT’s US pharmaceuticals correspondent Jamie Smyth on what...
September 28, 2022

Previous pagePage 1 of 135Next page